Dr. Reddy's Laboratories
DRREDDY · Pharma > Pharmaceuticals & Drugs · Chairman: K Satish Reddy · MD: GV Prasad · Listing date: Oct. 24, 1994 · Employees: 22739 · Hyderabad · http://www.drreddys.com

Stock Price vs Company Growth
1d
1.3%
1w
5.9%
1m
15.4%
3m
14.1%
6m
7.9%
1y
11.2%
5y
4.4%
10y
7.5%
all
11.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,136 1.3%
1,080
1,406
Company Overview

Sales
33,228 Cr
Growth: 2.1%
Profit after Tax
3,222 Cr
Growth: -23.2%
Large Cap
94,790 Cr
P/E: 29.4x
Industry P/E: 32.3x
Fundamentals

Sales (Cr) ₹ 33,228
Growth 2.1%
EBITDA 15.5%
P/S 2.9x
Dividend 0.6%
P/E 29.4x
Book Value ₹ 459
PEG Ratio 13.7x
ROE 8.6%
P/B 2.5x
Shareholding Pattern

Institutions
First Senter Investors Icvc- Stewart Investors Asia Pacific Leaders Sustainability Fund
3.37 %
Life Insurance Corporation Of India P & Gs Fund
2.34 %
Sbi Mutual Fund
2.11 %
Aditya Birla Mutual Fund
1.96 %
Government Of Singapore - E
1.77 %
Promoters
Dr. Reddy'S Holdings Limited
24.84 %
Gunupati Venkateswara Prasad (Huf)
0.67 %
Samrajyam Reddy Kallam
0.67 %
Satish Reddy Kallam
0.54 %
Others
Jp Morgan Chase Bank, Na
12.09 %
Icici Prudential Life Insurance Company Limited
1.38 %
Nps Trust - A/C
1.27 %
Iepf
0.14 %
Increase    Decrease    No change
Company Profile Detailed

The company is a multinational pharmaceutical company that manufactures and markets a wide range of pharmaceutical products and services. Through its businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.
Investors (388)
Followers (34)